When to consider antiobesity drugs or bariatric surgery

J Pinkney; D Kerrigan

When to consider antiobesity drugs or bariatric surgery

J Pinkney
, D Kerrigan

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

Abstract

Most people with type 2 diabetes are either overweight or obese, and many are severely so. Although the potential benefits of weight loss for people with type 2 diabetes are profound, weight loss is seldom a major treatment goal, and many diabetes-trained healthcare professionals remain ill-equipped to help patients tackle their obesity. This article examines the current evidence for offering antiobesity drugs or bariatric surgery in the routine management of type 2 diabetes and suggests when and in whom these treatment modalities should be considered.

Original language	English
Number of pages	0
Journal	Diabetes and Primary Care
Volume	9
Issue number	2
Publication status	Published - 1 Dec 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{bbd4191047274eb88d42ee773d72242c,

title = "When to consider antiobesity drugs or bariatric surgery",

abstract = "Most people with type 2 diabetes are either overweight or obese, and many are severely so. Although the potential benefits of weight loss for people with type 2 diabetes are profound, weight loss is seldom a major treatment goal, and many diabetes-trained healthcare professionals remain ill-equipped to help patients tackle their obesity. This article examines the current evidence for offering antiobesity drugs or bariatric surgery in the routine management of type 2 diabetes and suggests when and in whom these treatment modalities should be considered.",

author = "J Pinkney and D Kerrigan",

year = "2007",

month = dec,

day = "1",

language = "English",

volume = "9",

journal = "Diabetes and Primary Care",

issn = "1466-8955",

number = "2",

}

TY - JOUR

T1 - When to consider antiobesity drugs or bariatric surgery

AU - Pinkney, J

AU - Kerrigan, D

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Most people with type 2 diabetes are either overweight or obese, and many are severely so. Although the potential benefits of weight loss for people with type 2 diabetes are profound, weight loss is seldom a major treatment goal, and many diabetes-trained healthcare professionals remain ill-equipped to help patients tackle their obesity. This article examines the current evidence for offering antiobesity drugs or bariatric surgery in the routine management of type 2 diabetes and suggests when and in whom these treatment modalities should be considered.

AB - Most people with type 2 diabetes are either overweight or obese, and many are severely so. Although the potential benefits of weight loss for people with type 2 diabetes are profound, weight loss is seldom a major treatment goal, and many diabetes-trained healthcare professionals remain ill-equipped to help patients tackle their obesity. This article examines the current evidence for offering antiobesity drugs or bariatric surgery in the routine management of type 2 diabetes and suggests when and in whom these treatment modalities should be considered.

M3 - Article

SN - 1466-8955

VL - 9

JO - Diabetes and Primary Care

JF - Diabetes and Primary Care

IS - 2

ER -

When to consider antiobesity drugs or bariatric surgery

Abstract

UN SDGs

Fingerprint

Cite this